Technical Analysis for ETON - Eton Pharmaceutcials, Inc.

Grade Last Price % Change Price Change
grade C 6.01 -0.17% -0.01
ETON closed down 0.17 percent on Thursday, December 13, 2018, on 26 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical ETON trend table...

Date Alert Name Type % Chg
Dec 13 20 DMA Resistance Bearish 0.00%
Dec 13 NR7 Range Contraction 0.00%
Dec 13 Oversold Stochastic Weakness 0.00%
Dec 12 Hot IPO Pullback Bullish Swing Setup -0.17%
Dec 12 Stochastic Reached Oversold Weakness -0.17%
Dec 12 Inside Day Range Contraction -0.17%
Dec 11 Hot IPO Pullback Bullish Swing Setup -2.28%
Dec 10 Hot IPO Pullback Bullish Swing Setup -1.15%
Dec 10 Outside Day Range Expansion -1.15%
Dec 7 Hot IPO Pullback Bullish Swing Setup -2.28%

Older signals for ETON ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical product using the U.S. Food and Drug Administration's 505(b)(2) regulatory pathway. It primarily focuses on liquid products, including injectable, oral liquid, and ophthalmic products. The company is developing DS-300, an injectable nutrition product candidate; EM-100, an ophthalmic product for the treatment of allergic conjunctivitis; ET-103, an oral liquid product candidate; DS-100, an injectable product candidate for use in pain management; DS-200, an injectable parenteral nutrition product candidate; ET-101, an oral liquid product for use in seizure control; ET-102, an oral liquid product for use as a muscle relaxant; and CT-100, a synthetic corticotropin therapeutic candidate that mimics the amino acid chain of H.P. Acthar Gel. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Is ETON a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 0 bearish and 5 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.68
52 Week Low 5.9
Average Volume 27,701
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 6.1275
10-Day Moving Average 6.16
Average True Range 0.2737
ADX 0.0
+DI 15.2979
-DI 8.5545
Chandelier Exit (Long, 3 ATRs ) 5.8589
Chandelier Exit (Short, 3 ATRs ) 6.7211
Upper Bollinger Band 6.404
Lower Bollinger Band 5.851
Percent B (%b) 0.29
BandWidth 9.024888
MACD Line -0.0168
MACD Signal Line 0.0064
MACD Histogram -0.0232
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.22
Resistance 3 (R3) 6.24 6.20 6.19
Resistance 2 (R2) 6.20 6.14 6.19 6.17
Resistance 1 (R1) 6.10 6.11 6.08 6.08 6.16
Pivot Point 6.06 6.06 6.05 6.05 6.06
Support 1 (S1) 5.96 6.00 5.94 5.94 5.86
Support 2 (S2) 5.92 5.97 5.91 5.85
Support 3 (S3) 5.82 5.92 5.84
Support 4 (S4) 5.80